|Classification and external resources|
Anhedonia is the inability to experience pleasure from activities usually found enjoyable, e.g. exercise, hobbies, singing, sexual activities or social interactions. While earlier definitions of anhedonia emphasized pleasurable experience, more recent models have highlighted the need to consider different aspects of enjoyable behavior, such as motivation or desire to engage in activities (motivational anhedonia), as compared to the level of enjoyment of the activity itself ("consummatory anhedonia").
One can distinguish many kinds of pathological depression. Sometimes it is mere passive joylessness and dreariness, discouragement, dejection, lack of taste and zest and spring. Professor Ribot proposed the name anhedonia to designate this condition. "The state of anhedonia, if I may coin a new word to pair off with analgesia," he writes, "has been very little studied, but it exists."
Anhedonia can be a characteristic of mental disorders, including mood disorders, attention deficit hyperactivity disorder, schizoaffective disorder, borderline personality disorder, schizoid personality disorder, dysthymia and schizophrenia. For example, the 7th DSM-IV criterion for Borderline Personality Disorder: "chronic feelings of emptiness." Results indicate that emptiness is negligibly related to boredom, is closely related to feeling hopeless, pathologically lonely, and isolated, and is a robust predictor of depression and suicidal ideation (but not anxiety or suicide attempts). Findings are consistent with DSM-IV revisions regarding the 7th criterion for Borderline Personality Disorder. In addition, findings suggest the emptiness reflects pathologically low positive affect and significant psychiatric distress. People affected with schizophrenia often describe themselves as feeling emotionally empty.
Mood disturbances are commonly observed in many psychiatric disorders such as major depressive disorder. Disturbing mood changes may occur resultant to stressful life events and they are not uncommon during times of physical illness. While anhedonia can be a feature of such mood changes, they are not mutually inclusive. The word is from Greek: ἀν- an-, "without" and ἡδονή hēdonē, "pleasure".
Researchers theorize that anhedonia may result from the breakdown in the brain's reward system, involving the neurotransmitter dopamine. Studies by Paul Keedwell, MD, then of King's College, found that the brains of participants who were clinically depressed had to work harder to process rewarding experiences. While earlier research believed dopamine to be primarily involved in the subjective experience of pleasure, the last 20 years has seen a conceptual shift, such that dopamine is now believed to underlie various aspects of reward anticipation, learning, and motivation. Anhedonia can be characterised as "impaired ability to pursue, experience and/or learn about pleasure, which is often, but not always accessible to conscious awareness".
Anhedonia is also a relatively common side effect of antidopaminergic neuroleptics or antipsychotic drugs. It can also be a side effect of withdrawal from stimulants such as phenethylamines, or amphetamines and opioids such as heroin and morphine.
Significance in depressionEdit
Anhedonia is a core symptom of Major Depressive Disorder, therefore individuals experiencing this symptom can be diagnosed with depression, even in the absence of low/depressed mood. The Diagnostic and Statistical Manual of Mental Disorders (DSM) describes a "lack of interest or pleasure", but these can be difficult to discern given that people tend to become less interested in things which do not give them pleasure. The DSM criterion of weight loss is probably related, and many individuals with this symptom describe a lack of enjoyment of food. People suffering from anhedonia in association with depression generally feel suicidal in the morning and better in the evenings as sleep seems the only escape resembling death and can portray any of the non-psychotic symptoms and signs of depression.
Sexual anhedonia in males is also known as 'ejaculatory anhedonia'. This condition means that the person will ejaculate with no accompanying sense of pleasure.
The condition is most frequently found in males, but women can suffer from lack of pleasure when the body goes through the orgasm process as well.
Sexual anhedonia may be caused by:
- Hypoactive sexual desire disorder (HSDD), also called inhibited sexual desire
- Low levels of the hormone testosterone
- Spinal cord injury
- Multiple sclerosis
- Use of SSRI antidepressants
- Use (or previous use) of antidopaminergic neuroleptics (anti-psychotics)
- Physical illness
It is very uncommon that a neurological examination and blood tests can determine the cause of a specific case of sexual anhedonia.
Social anhedonia is defined as a trait-like disinterest in social contact and is characterized by social withdrawal and decreased pleasure in social situations. This characteristic typically manifests as an indifference to other people. In contrast to introversion, a nonpathological dimension of human personality, social anhedonia represents a deficit in the ability to experience pleasure. Additionally, social anhedonia differs from social anxiety in that social anhedonia is predominantly typified by diminished positive affect, while social anxiety is distinguished by both decreased positive affect and exaggerated negative affect. This trait is currently seen as a central characteristic to, as well as a predictor of, schizophrenia-spectrum disorders, as it is seen as a potential evolution of most personality disorders, if the patient is above age 24, when prodromal schizophrenia may be excluded.
- Decreased ability to experience interpersonal pleasure
- Social withdrawal/isolation
- Decreased need for social contact
- Lack of close friends and intimate relationships, and decreased quality of those relationships
- Poor social adjustment
- Decreased positive affect
- Flat affect
- Depressed mood
- State-related anxiety
Social anhedonia is trait-related, meaning it remains stable throughout life, independent of diagnosis, treatment, or symptom remission.
Background and early clinical observationEdit
The term anhedonia is derived from the Greek an-, "without" and hēdonē, "pleasure". Interest in the nature of pleasure and its absence dates back to ancient Greek philosophers such as Epicurus. The symptoms of anhedonia were introduced to the realm of psychopathology in 1809 by John Haslam, who characterized a patient suffering from schizophrenia as indifferent to “those objects and pursuits which formerly proved sources of delight and instruction.”. The concept was formally coined by Théodule-Armand Ribot and later used by psychiatrists Paul Eugen Bleuler and Emil Kraepelin to describe a core symptom of schizophrenia. Theorists Sándor Radó and Paul Meehl posited that anhedonia represents an underlying genetic vulnerability to schizophrenia-spectrum disorders. In particular, Rado postulated that schizotypes, or individuals with the schizophrenic phenotype, have two key genetic deficits, one related to the ability to feel pleasure (anhedonia) and one related to proprioception. In 1962 Meehl furthered Rado's theory through the introduction of the concept of schizotaxia, a genetically-driven neural integrative defect thought to give rise to the personality type of schizotypy. Loren and Jean Chapman further distinguished between two types of anhedonia: physical anhedonia, or a deficit in the ability to experience physical pleasure, and social, or a deficit in the ability to experience interpersonal pleasure.
Recent research suggests that social anhedonia may represent a prodrome of psychotic disorders. First-degree relatives of individuals with schizophrenia show elevated levels of social anhedonia, higher baseline scores of social anhedonia are associated with later development of schizophrenia. These findings provide support for the conjecture that it represents a genetic risk marker for schizophrenia-spectrum disorders.
Additionally, elevated levels of social anhedonia in patients with schizophrenia have been linked to poorer social functioning. Socially anhedonic individuals perform worse on a number of neuropsychological tests than non-anhedonic participants, and show similar physiological abnormalities seen in patients with schizophrenia.
Anhedonia is present in several forms of psychopathology. However, social anhedonia is not a necessary symptom criterion of any disorder. Social anhedonia manifests similarly in a variety of different mental illness, but for differing reasons. Most frequently, social anhedonia is associated with schizophrenia and schizophrenia spectrum disorders (including schizotypal personality disorder, paranoid personality disorder, and schizoid personality disorder). Social anhedonia has also been implicated in other psychological disorders:
Social anhedonia is observed in both depression and schizophrenia. However, social anhedonia is state related to the depressive episode and the other is trait related to the personality construct associated with schizophrenia. These individuals both tend to score highly on self-report measures of social anhedonia. Blanchard, Horan, and Brown (2001) demonstrated that, although both the depression and the schizophrenia patient groups can look very similar in terms of social anhedonia cross sectionally, over time as individuals with depression experience symptom remission, they show fewer signs of social anhedonia, while individuals with schizophrenia do not. Blanchard and colleagues (2011) found individuals with social anhedonia also had elevated rates of lifetime mood disorders including depression and dysthymia compared to controls.
As mentioned above, social anxiety and social anhedonia differ in important ways. However, social anhedonia and social anxiety are also often comorbid with each other. People with social anhedonia may display increased social anxiety and be at increased risk for social phobias and generalized anxiety disorder. It has yet to be determined what the exact relationship between social anhedonia and social anxiety is, and if one potentiates the other. Individuals with social anhedonia may display increased stress reactivity, meaning that they feel more overwhelmed or helpless in response to a stressful event compared to control subjects who experience the same type of stressor. This dysfunctional stress reactivity may correlate with hedonic capacity, providing a potential explanation for the increased anxiety symptoms experienced in people with social anhedonia. In an attempt to separate out social anhedonia from social anxiety, the Revised Social Anhedonia Scale  didn't include items that potentially targeted social anxiety. However, more research must be conducted on the underlying mechanisms through which social anhedonia overlaps and interacts with social anxiety. The efforts of the “social processes” RDoC initiative will be crucial in differentiating between these components of social behavior that may underlie mental illnesses such as schizophrenia.
Primary relevance in schizophrenia and schizophrenia spectrum disordersEdit
Social anhedonia is a core characteristic of schizotypy, which is defined as a continuum of personality traits that can range from normal to disordered and contributes to risk for psychosis and schizophrenia. Social anhedonia is a dimension of both negative and positive schizotypy. It involves social and interpersonal deficits, but is also associated with cognitive slippage and disorganized speech, both of which fall into the category of positive schizotypy. Not all people with schizophrenia display social anhedonia  and likewise, people who have social anhedonia may never be diagnosed with a schizophrenia-spectrum disorder if they do not have the positive and cognitive symptoms that are most frequently associated with most schizophrenia-spectrum disorders.
Social anhedonia may be a valid predictor of future schizophrenia-spectrum disorders; young adults with social anhedonia perform in a similar direction to schizophrenia patients in tests of cognition and social behavior, showing potential predictive validity. Social anhedonia usually manifests in adolescence, possibly because of a combination of the occurrence of critical neuronal development and synaptic pruning of brain regions important for social behavior and environmental changes, when adolescents are in the process of becoming individuals and gaining more independence.
There is no validated treatment for social anhedonia. Future research should focus on genetic and environmental risk factors to home in on specific brain regions and neurotransmitters that may be implicated in social anhedonia's cause and could be targeted with medication or behavioral treatments. Social support may also play a valuable role in the treatment of social anhedonia. Blanchard et al. (2011)  found that a greater number of social supports as well as a greater perceived social support network were related to fewer schizophrenia-spectrum symptoms and to better general functioning within the social anhedonia group.
In the general population, males score higher than females on measures of social anhedonia. This sex difference is stable throughout time (from adolescence into adulthood) and is also seen in people with schizophrenia-spectrum disorders. These results may reflect a more broad pattern of interpersonal and social deficits seen in schizophrenia-spectrum disorders. On average, males with schizophrenia are diagnosed at a younger age, have more severe symptoms, worse treatment prognosis, and a decrease in overall quality of life compared to females with the disorder. These results, coupled with the sex difference seen in social anhedonia, outline the necessity for research on genetic and hormonal characteristics that differ between males and females, and that may increase risk or resilience for mental illnesses such as schizophrenia.
There are several self-report psychometric measures of schizotypy which each contain subscales related to social anhedonia:
- Revised Social Anhedonia Scale—Chapman Psychosis Proneness Scales
- No Close Friends Subscale—Schizotypyal Personality Questionnaire 
- Introverted Anhedonia Subscale—Oxford Liverpool Inventory of Feelings & Experiences 
L.J. and J.P. Chapman were the first to discuss the possibility that social anhedonia may stem from a genetic vulnerability. The Disrupted in Schizophrenia 1 (DISC1) gene has been consistently associated with risk for, and cause of, schizophrenia-spectrum disorders and other mental illnesses. More recently, DISC1 has been associated with social anhedonia within the general population. Tomppo (2009) identified a specific DISC1 allele that is associated with an increase in characteristics of social anhedonia. They also identified a DISC1 allele associated with decreased characteristics of social anhedonia, that was found to be preferentially expressed in women. More research needs to be conducted, but social anhedonia may be an important intermediate phenotype (endophenotype) between genes associated with risk for schizophrenia and phenotype of the disorder. Continued study of social anhedonia and its genetic components will help researchers and clinicians learn more about the cause of schizophrenia-spectrum disorders.
Researchers studying the neurobiology of social anhedonia posit that this trait may be linked to dysfunction of reward-related systems in the brain. This circuitry is critical for the sensation of pleasure, the computation of reward benefits and costs, determination of the effort required to obtain a pleasant stimulus, deciding to obtain that stimulus, and increasing motivation to obtain the stimulus. In particular, the ventral striatum and areas of the prefrontal cortex (PFC), including the orbitofrontal cortex (OFC) and dorsolateral (dl) PFC, are critically involved in the experience of pleasure and the hedonic perception of rewards. With regards to neurotransmitter systems, opioid, gamma-Aminobutyric acid and endocannabinoid systems in the nucleus accumbens, ventral pallidum, and OFC mediate the hedonic perception of rewards. Activity in the PFC and ventral striatum have been found to be decreased in anhedonic individuals with Major Depressive Disorder (MDD) and schizophrenia. However, schizophrenia may be less associated with decreased hedonic capacity and more with deficient reward appraisal. Abnormal functioning of the anterior insula and the parietal cortex is also implicated in anhedonia. Dowd & Barch conducted an fMRI study in which schizophrenia-spectrum disorder patients and control participants made valence and arousal ratings of their own responses to emotional stimuli. They found that higher levels of anhedonia were associated with diminished arousal, but not valence, ratings. Furthermore, they found that, in controls, greater levels of social anhedonia were related to decreased bilateral caudate activation in response to positive relative to negative stimuli. The authors posit that the striatum in anhedonic individuals might be dysfunctional such that it fails to tag the saliency of positive events. Consequently, these individuals may experience blunted emotion.
Research further implicates that abnormalities in the circuitry underlying social cognition are also critically involved in the generation of anhedonic symptoms. Individuals high in social anhedonia show less activation in the anterior portion of the rostral medial prefrontal cortex (arMFC), right superior temporal gyrus, and left somatosensory cortex during an emotion discrimination task; these regions are responsible for processing facial emotions. Moreover, the arMFC is highly relevant for social cognition, and the mPFC and somatosensory cortex are involved in theory of mind and mentalizing. Thus, social anhedonia appears to be related to dysfunction of neural systems involved in self/other representation and social perception.
Specific musical anhedoniaEdit
Recent studies have found people who do not have any issue processing musical tones or beat, yet receive no pleasure from listening to music. Specific musical anhedonia is distinct from melophobia, the fear of music.
- Treadway MT, Zald DH (2011). "Reconsidering anhedonia in depression: lessons from translational neuroscience". Neurosci Biobehav Rev. 35 (3): 537–555. doi:10.1016/j.neubiorev.2010.06.006. PMC . PMID 20603146.
- Varieties of Religious Experience Lecture VI, The Sick Soul, William James 1902
- Klonsky, ED (2008). "What is emptiness? Clarifying the 7th criterion for borderline personality disorder". Journal of Personality Disorders. 22 (4): 418–26. doi:10.1521/pedi.2008.22.4.418. PMID 18684053.
- Hales R., Yudofsky S., Talbott J. 1999. Textbook of Psychiatry 3rd ed. Washington DC: The American Psychiatric Press.[page needed]
- Gelder, Michael G.; Mayou, Richard; Geddes, John; Geddes, John (2005). Psychiatry (3rd ed.). Oxford University Press. pp. 2, 99. ISBN 978-0-19-852863-0.
- John McManamy, "No Pleasure, No Reward – Plenty of Depression", URL accessed 2009-02-17[self-published source?]
- Surguladze, S. (2003). "Neural systems underlying affective disorders". Advances in Psychiatric Treatment. 9 (6): 446–55. doi:10.1192/apt.9.6.446.
- Berridge K. C. (2007). "The debate over dopamine's role in reward: the case for incentive salience". Psychopharmacology. 191 (3): 391–431. doi:10.1007/s00213-006-0578-x. PMID 17072591.
- Salamone J. D.; Correa M.; Farrar A.; Mingote S. M. (2007). "Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits". Psychopharmacology. 191 (3): 461–482. doi:10.1007/s00213-006-0668-9. PMID 17225164.
- Schultz W (2007). "Multiple dopamine functions at different time courses". Annu Rev Neurosci. 30: 259–288. doi:10.1146/annurev.neuro.28.061604.135722. PMID 17600522.
- Rømer Thomsen K, Whybrow PC, Kringelbach ML (2015). "Reconceptualizing anhedonia: novel perspectives on balancing the pleasure networks in the human brain". Front Behav Neurosci. 9: 49. doi:10.3389/fnbeh.2015.00049. PMC . PMID 25814941.
- American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5. Washington, D.C: American Psychiatric Association.
- Tomb, David A. (1 August 2007). Psychiatry. Lippincott Williams & Wilkins. p. 44. ISBN 978-0-7817-7452-9. Retrieved 18 December 2010.
- Csoka, Antonei; Bahrick, Audrey; Mehtonen, Olli-Pekka (2007). "Persistent Sexual Dysfunction after Discontinuation of Selective Serotonin Reuptake Inhibitors". Journal of Sexual Medicine. 5 (1): 227–233. doi:10.1111/j.1743-6109.2007.00630.x. PMID 18173768.
- Tupala, E; Haapalinna, A; Viitamaa, T; Männistö, PT; Saano, V (1999). "Effects of repeated low dose administration and withdrawal of haloperidol on sexual behaviour of male rats". Pharmacology & toxicology. 84 (6): 292–5. doi:10.1111/j.1600-0773.1999.tb01497.x. PMID 10401732.
- Martin-Du Pan, R (1978). "Neuroleptics and sexual dysfunction in man. Neuroendocrine aspects". Schweizer Archiv für Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie. 122 (2): 285–313. PMID 29337.
- Crenshaw, Theresa L.; Goldberg, James P.; Stern, Warren C. (1987). "Pharmacologic modification of psychosexual dysfunction". Journal of Sex & Marital Therapy. 13 (4): 239–52. doi:10.1080/00926238708403896. PMID 3121861.
- Blanchard J.J.; Gangestad S.W.; Brown S.A.; Horan W.P. (2000). "Hedonic capacity and schizotypy revisited: A taxometric analysis of social anhedonia". Journal of Abnormal Psychology. 109 (1): 87–95. doi:10.1037/0021-843x.109.1.87. PMID 10740939.
- Silvia, P. J.; Kwapil, T. R. (2011). "Aberrant asociality: How individual differences in social anhedonia illuminate the need to belong". Journal of Personality. 79 (6): 1315–32. doi:10.1111/j.1467-6494.2010.00702.x. PMID 21480908.
- Brown L.H.; Silvia P.J.; Myin-Germeys I.; Lewandowski K.E.; Kwapil T.R. (2008). "The relationship of social anxiety and social anhedonia to psychometrically identified schizotypy". Journal of Social and Clinical Psychology. 27 (2): 127–149. doi:10.1521/jscp.2008.27.2.127.
- Kwapil T.R. (1998). "Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders". Journal of Abnormal Psychology. 107 (4): 558–565. doi:10.1037/0021-843x.107.4.558. PMID 9830243.
- DSM-5® Clinical Cases John W. Barnhill, M.D.
- Mishlove M.; Chapman L. J. (1985). "Social anhedonia in the prediction of psychosis proneness". Journal of Abnormal Psychology. 94 (3): 384–396. doi:10.1037/0021-843x.94.3.384. PMID 4031235.
- Blanchard J. J.; Mueser K. T.; Bellack A. S. (1998). "Anhedonia, positive and negative affect, and social functioning in schizophrenia". Schizophrenia bulletin. 24 (3): 413–424. doi:10.1093/oxfordjournals.schbul.a033336. PMID 9718633.
- Di Giannantonio M.; Martinotti G. (2012). "Anhedonia and major depression: The role of agomelatine". European neuropsychopharmacology. 22 (Suppl 3): S505–S510. doi:10.1016/j.euroneuro.2012.07.004. PMID 22959116.
- Der-Avakian A.; Markou A. (2011). "The neurobiology of anhedonia and other reward-related deficits". Trends in Neurosciences. 35 (1): 68–77. doi:10.1016/j.tins.2011.11.005. PMC . PMID 22177980.
- Noll, R. (1959). The encyclopedia of schizophrenia and other psychotic disorders (p. xii). New York : Facts on File.
- Horan W.P.; Kring A.M.; Blanchard J.J. (2006). "Anhedonia in Schizophrenia: A Review of Assessment Strategies". Schizophrenia Bulletin. 32 (2): 259–273. doi:10.1093/schbul/sbj009. PMC . PMID 16221997.
- Meehl P.E. (1989). "Schizotaxia revisited". Archives of General Psychiatry. 46 (10): 935–944. doi:10.1001/archpsyc.1989.01810100077015. PMID 2552952.
- Kontaxakis V.; Kollias C.; Margariti M.; Stamouli S.; Petridou E.; Christodoulou G.N. (2006). "Physical anhedonia in the acute phase of schizophrenia". Annals of General Psychiatry. 5: 1–6. doi:10.1186/1744-859X-5-1.
- Mann, Monica Constance (2006). "Verbal and Nonverbal Expressions as Indicators of Social and Emotional Functioning among Social Anhedonics". hdl:1903/3594. Master's Thesis. University of Maryland, College Park. College Park, MD.
- Cohen A.S.; Emmerson L.C.; Mann M.C.; Forbes C.B.; Blanchard J.J. (2010). "Schizotypal, schizoid and paranoid characteristics in the biological parents of social anhedonics". Psychiatry Research. 178 (1): 79–83. doi:10.1016/j.psychres.2008.07.018. PMC . PMID 20452676.
- Gooding D.C.; Tallent K.A.; Matts C.W. (2005). "Clinical status of at-risk individuals five years later: Further validation of the psychometric high-risk strategy". Journal of Abnormal Psychology. 114 (1): 170–175. doi:10.1037/0021-843x.114.1.170. PMID 15709824.
- Blanchard J.J.; Bellack A.S.; Mueser K.T. (1994). "Affective and social-behavioral correlates of physical and social anhedonia in schizophrenia". Journal of Abnormal Psychology. 103 (4): 719–728. doi:10.1037/0021-843x.103.4.719. PMID 7822573.
- Laurent A.; Biloa-Tang M.; Bougerol T.; Duly D.; Anchisi A.M.; Bosson J.L.; Pellat J.; Amato T.; Dalery J. (2000). "Executive/ attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic first-degree relatives". Schizophrenia Research. 46 (2–3): 269–283. doi:10.1016/s0920-9964(99)00232-7. PMID 11120438.
- Cohen A.S.; Leung W.W.; Saperstein A.M.; Blanchard J.J. (2006). "Neuropsychological functioning and social anhedonia: results from a community high-risk study". Schizophrenia Research. 85 (1–3): 132–141. doi:10.1016/j.schres.2006.03.044. PMID 16730428.
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. (2000). Washington, DC, American Psychiatric Association.
- Blanchard J.J.; Horan W.P.; Brown S.A. (2001). "Diagnostic differences in social anhedonia: A longitudinal study of schizophrenia and major depressive disorder". Journal of Abnormal Psychology. 110 (3): 363–371. doi:10.1037/0021-843x.110.3.363. PMID 11502079.
- Blanchard J.J.; Collins L.M.; Aghevli M.; Leung W.W.; Cohen A.S. (2011). "Social anhedonia and schizotypy in a community sample: the Maryland longitudinal study of schizotypy". Schizophrenia Bulletin. 37 (3): 587–602. doi:10.1093/schbul/sbp107. PMC . PMID 19850669.
- Rey G.; Jouvent R.; Dubal S. (2009). "Schizotypy, depression, and anxiety in physical and social anhedonia". Journal of clinical psychology. 65 (7): 695–708. doi:10.1002/jclp.20577. PMID 19388058.
- Horan W. P.; Brown S. A.; Blanchard J. J. (2007). "Social anhedonia and schizotypy: the contribution of individual differences in affective traits, stress, and coping". Psychiatry Research. 149 (1–3): 147–156. doi:10.1016/j.psychres.2006.06.002. PMID 17109970.
- Eckblad, M.L., Chapman, L.J., Chapman, J.P., & Mishlove, M. (1982). The Revised Social Anhedonia Scale. Unpublished test
- Meehl PE (1962). "Schizotaxia, schizotypy, schizophrenia". The American Psychologist. 17 (12): 827–838. doi:10.1037/h0041029.
- Kwapil Thomas R; Barrantes-Vidal N.; Silvia P. J. (2008). "The dimensional structure of the Wisconsin Schizotypy Scales: factor identification and construct validity". Schizophrenia bulletin. 34 (3): 444–457. doi:10.1093/schbul/sbm098. PMC . PMID 17768308.
- Gooding D C; Tallent K. A.; Hegyi J. V. (2001). "Cognitive slippage in schizotypic individuals". The Journal of Nervous and Mental Disease. 189 (11): 750–756. doi:10.1097/00005053-200111000-00004. PMID 11758658.
- Kerns J. G. (2006). "Schizotypy facets, cognitive control, and emotion". Journal of Abnormal Psychology. 115 (3): 418–427. doi:10.1037/0021-843X.115.3.418. PMID 16866583.
- Collins L. M.; Blanchard J. J.; Biondo K. M. (2005). "Behavioral signs of schizoidia and schizotypy in social anhedonics". Schizophrenia Research. 78 (2–3): 309–322. doi:10.1016/j.schres.2005.04.021. PMID 15950438.
- Chapman L. J.; Chapman J. P.; Raulin M. L. (1976). "Scales for physical and social anhedonia". Journal of Abnormal Psychology. 85 (4): 374–382. doi:10.1037/0021-843x.85.4.374. PMID 956504.
- Chapman L. J.; Chapman J. P.; Kwapil T. R.; Eckblad M.; Zinser M. C. (1994). "Putatively psychosis-prone subjects 10 years later". Journal of Abnormal Psychology. 103 (2): 171–183. doi:10.1037/0021-843x.103.2.171. PMID 8040487.
- Fonseca-Pedrero E.; Lemos-Giráldez S.; Muñiz J.; García-Cueto E.; Campillo-Alvarez A. (2008). "Schizotypy in adolescence: the role of gender and age". The Journal of Nervous and Mental Disease. 196 (2): 161–165. doi:10.1097/nmd.0b013e318162aa79. PMID 18277226.
- Miettunen J.; Jääskeläinen E. (2010). "Sex differences in Wisconsin Schizotypy Scales--a meta-analysis". Schizophrenia bulletin. 36 (2): 347–358. doi:10.1093/schbul/sbn075. PMC . PMID 18644855.
- Leung A, Chue P (2000). "Sex differences in schizophrenia, a review of the literature". Acta Psychiatr Scand. 101 (401): 3–38. doi:10.1111/j.0065-1591.2000.0ap25.x.
- Jessen H. M.; Auger A. P. (2011). "Sex differences in epigenetic mechanisms may underlie risk and resilience for mental health disorders". Epigenetics. 6 (7): 857–861. doi:10.4161/epi.6.7.16517.
- Raine A (1991). "The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria". Schizophrenia Bulletin. 17 (4): 555–564. doi:10.1093/schbul/17.4.555. PMID 1805349.
- Mason O.; Claridge G.; Jackson M. (1995). "New scales for the assessment of schizotypy". Personality and Individual Differences. 18: 7–13. doi:10.1016/0191-8869(94)00132-c.
- Brandon Nicholas J, Sawa A (2011). "Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nature reviews". Neuroscience. 12 (12): 707–722. doi:10.1038/nrn3120. PMC . PMID 22095064.
- Tomppo L.; Hennah W.; Miettunen J.; Järvelin M.-R.; Veijola J.; Ripatti S.; Ekelund J. (2009). "Association of variants in DISC1 with psychosis-related traits in a large population cohort". Archives of General Psychiatry. 66 (2): 134–141. doi:10.1001/archgenpsychiatry.2008.524. PMC . PMID 19188535.
- Wolf D.H. (2006). "Anhedonia in schizophrenia". Current Psychiatry Reports. 8 (4): 322–328. doi:10.1007/s11920-006-0069-0. PMID 16879797.
- Gold J.M.; Waltz J.A.; Prentice K.J.; Morris S.E.; Heerey E.A. (2008). "Reward processing in schizophrenia: a deficit in the representation of value". Schizophrenia Bulletin. 34 (5): 835–847. doi:10.1093/schbul/sbn068. PMC . PMID 18591195.
- Dowd E.C.; Barch D.M. (2010). "Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators". Biological Psychiatry. 67 (10): 902–911. doi:10.1016/j.biopsych.2009.10.020. PMC . PMID 20004364.
- Germine L.; Garrido L.; Bruce L.; Hooker C. (2011). "Social anhedonia is associated with neural abnormalities during face emotion processing". NeuroImage. 58 (3): 935–945. doi:10.1016/j.neuroimage.2011.06.059. PMID 21763435.
- Mas-Herrero, Ernest; Zatorre, Robert J.; Rodriguez-Fornells, Antoni; Marco-Pallarés, Josep (2014). "Dissociation between Musical and Monetary Reward Responses in Specific Musical Anhedonia". Current Biology. 24 (6): 699–704. doi:10.1016/j.cub.2014.01.068. PMID 24613311.